AMRX
Amneal Pharmaceuticals, Inc. Class A Common Stock
NASDAQ: AMRX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$12.80
+0.51% today
Updated 2026-04-29
Market cap
$4.08B
P/E ratio
58.18
P/S ratio
1.35x
EPS (TTM)
$0.22
Dividend yield
—
52W range
$7 – $15
Volume
1.9M
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
2.39%
Operating margin
14.10%
ROE
-881.00%
ROA
7.32%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2014 | $785.62M | $176.93M | 57.23% | 28.38% | 22.52% |
| 2015 | $866.28M | $169.45M | 57.63% | 26.23% | 19.56% |
| 2016 | $1.02B | $207.38M | 58.68% | 27.98% | 20.37% |
| 2017 | $1.03B | $167.65M | 50.90% | 23.71% | 16.22% |
| 2018 | $1.66B | $-169.73M | 43.08% | -1.18% | -10.21% |
| 2019 | $1.63B | $-361.92M | 21.70% | -15.29% | -22.25% |
| 2020 | $1.99B | $91.06M | 31.54% | 4.57% | 4.57% |
| 2021 | $2.09B | $10.62M | 36.73% | 7.29% | 0.51% |
| 2022 | $2.21B | $-129.99M | 35.78% | -4.29% | -5.88% |
| 2023 | $2.39B | $-83.99M | 36.09% | 8.54% | -3.51% |
| 2024 | $2.79B | $-116.89M | 36.52% | 8.92% | -4.18% |
| 2025 | $3.02B | $72.06M | 37.63% | 14.02% | 2.39% |